News
MassBio CEO Kendalle Burlin O’Connell said that without "policy stability and renewed investment," we will cede leadership in ...
U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...
The Animal Reproductive Biotechnology Center will increase understandings of ruminant reproduction and work to address reproductive issues.
Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a ...
In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...
Capricor Therapeutics saw its shares fall 13% by the end of trading Monday as its investigational cell therapy deramiocel for ...
Microbiologist and entrepreneur Jesse Labbé excels at cultivating discovery and innovation. As the new director of the ...
Investors reacted negatively to the news. The company’s stock fell more than 16% yesterday. It’s also a setback in ...
The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and ...
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...
13hOpinion
Zacks Investment Research on MSNNew Strong Buy Stocks for May 6thList today: MAIA Biotechnology, Inc. MAIA: This immuno-oncology company has seen the Zacks Consensus Estimate for its current ...
Despite growing policy uncertainty, plenty of healthcare companies have managed to put up big returns, thanks to these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results